404 related articles for article (PubMed ID: 26143158)
21. Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction.
Nischalke HD; Nattermann J; Lichterfeld M; Woitas RP; Rockstroh JK; Sauerbruch T; Spengler U
AIDS Res Hum Retroviruses; 2004 Jul; 20(7):750-4. PubMed ID: 15307921
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 co-receptor CCR5 and CCR2 mutations among Greeks.
Papa A; Papadimitriou E; Adwan G; Clewley JP; Malissiovas N; Ntoutsos I; Alexiou S; Antoniadis A
FEMS Immunol Med Microbiol; 2000 May; 28(1):87-9. PubMed ID: 10767612
[TBL] [Abstract][Full Text] [Related]
23. Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration.
Venkatesan S; Petrovic A; Van Ryk DI; Locati M; Weissman D; Murphy PM
J Biol Chem; 2002 Jan; 277(3):2287-301. PubMed ID: 11604406
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.
Khamaikawin W; Saisawang C; Tassaneetrithep B; Bhukhai K; Phanthong P; Borwornpinyo S; Phuphuakrat A; Pasomsub E; Chaisavaneeyakorn S; Anurathapan U; Apiwattanakul N; Hongeng S
Sci Rep; 2024 May; 14(1):10852. PubMed ID: 38741006
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
[TBL] [Abstract][Full Text] [Related]
26. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.
Ellwanger JH; Kulmann-Leal B; Kaminski VL; Rodrigues AG; Bragatte MAS; Chies JAB
Virus Res; 2020 Sep; 286():198040. PubMed ID: 32479976
[TBL] [Abstract][Full Text] [Related]
27. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
Galvani AP; Novembre J
Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
[TBL] [Abstract][Full Text] [Related]
28. Detection of new mutant sites of HIV-1 coreceptor CCR5 among Saudi populations.
Abuelsaad AS; Al-Ghamdi AS; Al-Ghamdi AN; Alakkas EA; Alsulaimani AA; Al-Harthi AA; Abdel-Moneim AS
J Interferon Cytokine Res; 2013 Dec; 33(12):783-9. PubMed ID: 23742258
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
[TBL] [Abstract][Full Text] [Related]
30. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
[TBL] [Abstract][Full Text] [Related]
31. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
[TBL] [Abstract][Full Text] [Related]
32. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.
Mock U; Machowicz R; Hauber I; Horn S; Abramowski P; Berdien B; Hauber J; Fehse B
Nucleic Acids Res; 2015 Jun; 43(11):5560-71. PubMed ID: 25964300
[TBL] [Abstract][Full Text] [Related]
33. The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV.
Karuppusamy KV; Babu P; Thangavel S
Stem Cell Rev Rep; 2021 Oct; 17(5):1607-1618. PubMed ID: 33788143
[TBL] [Abstract][Full Text] [Related]
34. Frequency of CCR5 Gene 32-bp deletion in Pakistani ethnic groups.
Khaliq S; Hameed A; Ayub Q; Mazhar K; Mohyuddin A; Mansoor A; Mehdi SQ
Genet Test; 2002; 6(2):123-7. PubMed ID: 12215252
[TBL] [Abstract][Full Text] [Related]
35. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
36. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
37. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
38. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
[TBL] [Abstract][Full Text] [Related]
39. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
Kim A; Pettoello-Mantovani M; Goldstein H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
[TBL] [Abstract][Full Text] [Related]
40. A Novel Role for the Receptor of the Complement Cleavage Fragment C5a, C5aR1, in CCR5-Mediated Entry of HIV into Macrophages.
Moreno-Fernandez ME; Aliberti J; Groeneweg S; Köhl J; Chougnet CA
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):399-408. PubMed ID: 26537334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
